How does IDNA's PB Ratio compare to its peers?

Insufficient data to calculate IDNA's Price-To-Book Ratio vs. peers for valuation analysis.

How does IDNA's PB Ratio compare vs other companies in the Asian Healthcare Industry?

Insufficient data to calculate IDNA's Price-To-Book Ratio vs. industry for valuation analysis.

What is IDNA's PB Ratio compared to its Fair PB Ratio? This is the expected PB Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

Insufficient data to calculate IDNA's Price-To-Book Fair Ratio for valuation analysis.

What is the Fair Price of IDNA when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Insufficient data to calculate IDNA's fair value for valuation analysis.

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Insufficient data to show price forecast.

IDNA Genomics (CSE:IDNA) - Stock Price, News & Analysis

IDNA Stock Overview

Engages in the field of genomics and biotechnology and specializes in personalized health care. More details

IDNA fundamental analysis
Snowflake Score
Valuation	0/6
Future Growth	0/6
Past Performance	0/6
Financial Health	0/6
Dividends	0/6

Risk Analysis

Shares are highly illiquid

Has not reported any financial data

Does not have a meaningful market cap (€75M)

IDNA Genomics Public Ltd Competitors

GUPPY's

TSE:5127

JP¥12.5b

Optimax Holdings Berhad

KLSE:OPTIMAX

RM 353.1m

VITA 34

XTRA:V3V

€72.5m

23andMe Holding

NasdaqCM:ME

US$93.8m

Price History & Performance

Summary of all time highs, changes and price drops for IDNA Genomics
Historical stock prices
Current Share Price	€27.20
52 Week High	€28.00
52 Week Low	€24.00
Beta	0
11 Month Change	0.74%
3 Month Change	n/a
1 Year Change	n/a
33 Year Change	n/a
5 Year Change	n/a
Change since IPO	13.33%

Recent News & Updates

No updates

Recent updates

No updates

Shareholder Returns

	IDNA	CY Healthcare	CY Market
7D	0%	-1.3%	-1.6%
1Y	n/a	-2.1%	49.9%

Return vs Industry: Insufficient data to determine how IDNA performed against the CY Healthcare industry.

Return vs Market: Insufficient data to determine how IDNA performed against the CY Market.

Price Volatility

Is IDNA's price volatile compared to industry and market?
IDNA volatility
IDNA Average Weekly Movement	n/a
Healthcare Industry Average Movement	5.2%
Market Average Movement	4.6%
10% most volatile stocks in CY Market	11.2%
10% least volatile stocks in CY Market	2.5%

Stable Share Price: IDNA's share price has been volatile over the past 3 months compared to the CY market.

Volatility Over Time: Insufficient data to determine IDNA's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
2020	n/a	n/a	www.idnagenomicsplc.com

IDNA Genomics Public Ltd engages in the field of genomics and biotechnology and specializes in personalized health care. The company develops and provides genetic tests in the field of genomics. It also develops and markets pharmaceutical products.

IDNA Genomics Public Ltd Fundamentals Summary

How do IDNA Genomics's earnings and revenue compare to its market cap?
IDNA fundamental statistics
Market cap	€75.08m
Earnings (TTM)	€0
Revenue (TTM)	n/a

n/a

P/E Ratio

n/a

P/S Ratio

Is IDNA overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
IDNA income statement (TTM)
Revenue	€0
Cost of Revenue	€0
Gross Profit	€0
Other Expenses	€0
Earnings	€0

Last Reported Earnings

n/a

Next Earnings Date

n/a

Earnings per share (EPS)	0
Gross Margin	0.00%
Net Profit Margin	0.00%
Debt/Equity Ratio	0.0%

How did IDNA perform over the long term?

See historical performance and comparison